Poor
distribution of nanocarriers at the tumor site and insufficient
drug penetration into the tissue are major challenges in the development
of effective and safe cancer therapy. Here, we aim to enhance the
therapeutic effect of liposomes by accumulating doxorubicin-loaded
liposomes at high concentrations in and around the tumor, followed
by heat-triggered drug release to facilitate low-molecular-weight
drug penetration throughout the tumor. A cyclic RGD peptide (cRGD)
was incorporated into liposomes decorated with a thermosensitive polymer
that allowed precise tuning of drug release temperature (i.e., Polymer-lip)
to develop a targeted thermosensitive liposome (cRGD-Polymer-lip).
Compared with conventional thermosensitive liposomes, cRGD-Polymer-lip
enhanced the binding of liposomes to endothelial cells, leading to
their accumulation at the tumor site upon intravenous administration
in tumor-bearing mice. Drug release triggered by local heating strongly
inhibited tumor growth. Notably, tumor remission was achieved via
multiple administrations of cRGD-Polymer-lip and heat treatments.
Thus, combining the advantages of tumor neovascular targeting and
heat-triggered drug release, these liposomes offer high potential
for minimally invasive and effective cancer chemotherapy.